Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2007
03/15/2007CA2621820A1 Isoquinolines derivatives as igf-1r inhibitors
03/15/2007CA2621739A1 Composition of whey growth factor extract for reducing muscle inflammation
03/14/2007EP1762568A1 Pyrazole derivatives
03/14/2007EP1762558A1 Process for preparing transcription factors and their use
03/14/2007EP1762557A2 Aspirin-triggered lipid mediators
03/14/2007EP1761560A1 Peptide-based compounds
03/14/2007EP1761540A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
03/14/2007EP1761494A1 Chemical compounds i
03/14/2007EP1761485A1 Amidino compounds as cysteine protease inhibitors
03/14/2007EP1761269A1 Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases
03/14/2007EP1761263A1 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
03/14/2007EP1761250A1 Oral delivery system
03/14/2007EP1581165B1 Factor viia inhibiting compounds
03/14/2007EP1562936B1 Therapeutic piperazine compounds
03/14/2007EP1517895B1 8-(biaryl) quinoline pde4 inhibitors
03/14/2007EP1515949B1 Mitotic kinesin inhibitors
03/14/2007EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/14/2007EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same
03/14/2007EP1328507B1 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
03/14/2007EP1305434B1 A human disintegrin protein
03/14/2007EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
03/14/2007EP1253919A4 Method and compositions for treating an inflammatory disease
03/14/2007EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
03/14/2007EP1011637B1 Modulation of drug loading in multivesicular liposomes
03/14/2007CN1930190A Hyaluronic acid derivative and drug containing the same
03/14/2007CN1930180A L-saccharide glucose lipid a analogue
03/14/2007CN1930142A Antiinflammatory lactones
03/14/2007CN1929841A Pharmaceutical composition of (+)-erythro-mefloquine and its use
03/14/2007CN1929836A (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
03/14/2007CN1929824A Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid
03/14/2007CN1927878A Clematis chinensis total saponin and treatment action thereof for rheumatoild disease
03/14/2007CN1927371A Blood flow promoting pellet and preparing process thereof
03/14/2007CN1927351A Heat clearing and detoxicating drug for abating fever
03/14/2007CN1927349A Traditional Chinese medicine for treating rheumatism and its preparing process
03/14/2007CN1927319A Traditional Chinese medicine composition for dredging meridian, activating blood circulation and removing stasis
03/14/2007CN1927317A Process for preparing plaster for treating pain of waist and leg
03/14/2007CN1927304A Traditional Chinese medicine injection for treating pig fever symptom and preparation thereof
03/14/2007CN1927288A Preparing art of cassia twig and Tuckahoe composition and use thereof
03/14/2007CN1927283A Chinese medicine bone pain or anesthesia caused by cold and dampness
03/14/2007CN1927282A Preparation for treating arthritis and preparation method thereof
03/14/2007CN1927278A Children's Shuangqing dispersant tablet and method for making same
03/14/2007CN1927273A Bath agent for influenza defervesce and preparing method thereof
03/14/2007CN1927250A Pharmaceutical composition, its preparation method and application
03/14/2007CN1927246A Medicament for animals with heat clearing and detoxicating, detumescence and obstruction removing functions and preparing method thereof
03/14/2007CN1927238A Medicament for animals with heat clearing and detoxicating, detumescence and pain relieving functions and preparing method thereof
03/14/2007CN1927206A Lornoxicam composition for injection and preparation process thereof
03/14/2007CN1927191A Lornoxicam transdermal drug administration plaster and its preparation method
03/14/2007CN1304567C Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
03/14/2007CN1304425C Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition
03/14/2007CN1304424C Compounds with growth hormone releasing properties
03/14/2007CN1304422C Non-amidated omega-conotoxin VIIA and its prepn process and application
03/14/2007CN1304418C Nuclear factor-K B P65 subunit antagonistic peptide and its use
03/14/2007CN1304389C Piperidine derivatives useful as CCR5 antagonists
03/14/2007CN1304383C Benzothiazole derivatives
03/14/2007CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
03/14/2007CN1304379C Water-soluble phenylpyridazine compounds and compositions containing the same
03/14/2007CN1304377C Metalloproteinase inhibitors
03/14/2007CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
03/14/2007CN1304047C Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2
03/14/2007CN1304045C Arthralgia removing pills and their preparation
03/14/2007CN1304027C Bone nourishing and rheumatic treating pills and their preparation method
03/14/2007CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof
03/14/2007CN1304008C Medical compsns.
03/14/2007CN1303999C Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same
03/14/2007CN1303984C Method for prparing bee glue-ethyl cellulose microcapsule
03/13/2007US7189870 Cardiovascular disorders; antiinflammatory agents
03/13/2007US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology
03/13/2007US7189839 An isolated polynucleotide that encodes a polypeptide comprising an amino acid sequence that represents the extracellular domain, also called a cytokine-binding domain, of a new human soluble class II cytokine receptor designated Zcytor16; antiarthritic and -inflammatory agents; autoimmune diseases
03/13/2007US7189827 Fusion of Fc domains with biologically active peptides and a process for preparing pharmaceutical agents using biologically active peptides; recombinant proteins
03/13/2007US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases
03/13/2007US7189808 Use of carboxy-terminal fragment of Ki-67 protein or of an active part, fragment or homologue thereof as compound that can be used for intracellular transfer and for introduction into and release by cells; antiinflammatory, anticancer agents
03/13/2007US7189761 Nitric oxide donor composition and method for treatment of anal disorders
03/13/2007US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma
03/13/2007US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis
03/13/2007US7189739 Antiinflammatory agents; cardiovascular disorders; rheumatic disorders
03/13/2007US7189728 Inhibitors of dipeptidyl peptidase IV
03/13/2007US7189713 Piperidine derivatives
03/13/2007US7189707 Modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and
03/13/2007US7189525 Human enzymes of the metalloprotease family
03/13/2007US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/13/2007US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/13/2007CA2387533C Purine derivatives
03/13/2007CA2267224C Vitronectin receptor antagonists
03/13/2007CA2192209C Treatment of optic neuritis
03/13/2007CA2112866C Novel derivatives of 2-cyano-3-hydroxy-propenamides, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them
03/09/2007CA2559439A1 Compositions for inhibiting or reducing inflammation of skin
03/08/2007WO2007028050A1 Heterobifunctional pan-selectin inhibitors
03/08/2007WO2007027834A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
03/08/2007WO2007027477A2 Treating vulvodynia using prodrugs of gaba analogs
03/08/2007WO2007027233A2 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
03/08/2007WO2007026966A1 Thiomorpholine compound and process for preparing the same
03/08/2007WO2007026962A1 Phenylene derivative
03/08/2007WO2007026950A1 Pyridazinone derivatives used for the treatment of pain
03/08/2007WO2007026928A1 Therapeutic agent for neuropathic pain
03/08/2007WO2007026836A1 Novel therapeutic agent derived from marine organism
03/08/2007WO2007026771A1 Injection for intravenous drip
03/08/2007WO2007026742A1 Colonic delivery-type therapeutic agent for inflammatory bowel disease
03/08/2007WO2007026737A1 Prophylactic and/or therapeutic method for rheumatoid arthritis
03/08/2007WO2007025938A1 Non-steroidal compounds useful as glucocorticoid receptor modulators